PSMA PETCT in patients with highrisk prostate cancer

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=QKxPgEdLO2E

Professor Michael Hofman introduces the findings from the new study: • Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. • Michael S Hofman, Nathan Lawrentschuk, Roslyn J Francis, Colin Tang, Ian Vela, Paul Thomas, Natalie Rutherford, Jarad M Martin, Mark Frydenberg, Ramdave Shakher, Lih-Ming Wong, Kim Taubman, Sze Ting Lee, Edward Hsiao, Paul Roach, Michelle Nottage, Ian Kirkwood, Dickon Hayne, Emma Link, Petra Marusic, Anetta Matera, Alan Herschtal, Amir Iravani, Rodney J Hicks, Scott Williams, Declan G Murphy, for the proPSMA Study Group Collaborators* • Read the study: https://www.thelancet.com/journals/la... • NOTE: At 0:57, the second box in the sequence should read 'Randomised (n=302)' • Visit The Lancet at https://www.thelancet.com/journals/la... • Find out more at https://www.thelancet.com/?dgcid=yout... • * * • Continue this conversation on social! Follow us today at… • / thelancet • / thelancetmedicaljournal • / the-lancet

#############################

New on site